These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

548 related articles for article (PubMed ID: 25844902)

  • 1. Gq signaling causes glomerular injury by activating TRPC6.
    Wang L; Jirka G; Rosenberg PB; Buckley AF; Gomez JA; Fields TA; Winn MP; Spurney RF
    J Clin Invest; 2015 May; 125(5):1913-26. PubMed ID: 25844902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Calcium-Dependent Protease Calpain-1 Links TRPC6 Activity to Podocyte Injury.
    Verheijden KAT; Sonneveld R; Bakker-van Bebber M; Wetzels JFM; van der Vlag J; Nijenhuis T
    J Am Soc Nephrol; 2018 Aug; 29(8):2099-2109. PubMed ID: 29954830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcineurin (CN) activation promotes apoptosis of glomerular podocytes both in vitro and in vivo.
    Wang L; Chang JH; Paik SY; Tang Y; Eisner W; Spurney RF
    Mol Endocrinol; 2011 Aug; 25(8):1376-86. PubMed ID: 21622531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRPC6 channel as an emerging determinant of the podocyte injury susceptibility in kidney diseases.
    Ilatovskaya DV; Staruschenko A
    Am J Physiol Renal Physiol; 2015 Sep; 309(5):F393-7. PubMed ID: 26084930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway.
    Nijenhuis T; Sloan AJ; Hoenderop JG; Flesche J; van Goor H; Kistler AD; Bakker M; Bindels RJ; de Boer RA; Möller CC; Hamming I; Navis G; Wetzels JF; Berden JH; Reiser J; Faul C; van der Vlag J
    Am J Pathol; 2011 Oct; 179(4):1719-32. PubMed ID: 21839714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NADPH oxidase-derived ROS contributes to upregulation of TRPC6 expression in puromycin aminonucleoside-induced podocyte injury.
    Wang Z; Wei X; Zhang Y; Ma X; Li B; Zhang S; Du P; Zhang X; Yi F
    Cell Physiol Biochem; 2009; 24(5-6):619-26. PubMed ID: 19910702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D down-regulates TRPC6 expression in podocyte injury and proteinuric glomerular disease.
    Sonneveld R; Ferrè S; Hoenderop JG; Dijkman HB; Berden JH; Bindels RJ; Wetzels JF; van der Vlag J; Nijenhuis T
    Am J Pathol; 2013 Apr; 182(4):1196-204. PubMed ID: 23385000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of TRPC6 ion channels in podocytes - Implications for focal segmental glomerulosclerosis and acquired forms of proteinuric diseases.
    Szabó T; Ambrus L; Zákány N; Balla G; Bíró T
    Acta Physiol Hung; 2015 Sep; 102(3):241-51. PubMed ID: 26551740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-30 family members regulate calcium/calcineurin signaling in podocytes.
    Wu J; Zheng C; Wang X; Yun S; Zhao Y; Liu L; Lu Y; Ye Y; Zhu X; Zhang C; Shi S; Liu Z
    J Clin Invest; 2015 Nov; 125(11):4091-106. PubMed ID: 26436650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient receptor potential channel 6 (TRPC6) protects podocytes during complement-mediated glomerular disease.
    Kistler AD; Singh G; Altintas MM; Yu H; Fernandez IC; Gu C; Wilson C; Srivastava SK; Dietrich A; Walz K; Kerjaschki D; Ruiz P; Dryer S; Sever S; Dinda AK; Faul C; Reiser J
    J Biol Chem; 2013 Dec; 288(51):36598-609. PubMed ID: 24194522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockout of TRPC6 promotes insulin resistance and exacerbates glomerular injury in Akita mice.
    Wang L; Chang JH; Buckley AF; Spurney RF
    Kidney Int; 2019 Feb; 95(2):321-332. PubMed ID: 30665571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Podocyte-specific overexpression of wild type or mutant trpc6 in mice is sufficient to cause glomerular disease.
    Krall P; Canales CP; Kairath P; Carmona-Mora P; Molina J; Carpio JD; Ruiz P; Mezzano SA; Li J; Wei C; Reiser J; Young JI; Walz K
    PLoS One; 2010 Sep; 5(9):e12859. PubMed ID: 20877463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of NFAT signaling in podocytes causes glomerulosclerosis.
    Wang Y; Jarad G; Tripathi P; Pan M; Cunningham J; Martin DR; Liapis H; Miner JH; Chen F
    J Am Soc Nephrol; 2010 Oct; 21(10):1657-66. PubMed ID: 20651158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRPC6 and FSGS: the latest TRP channelopathy.
    Mukerji N; Damodaran TV; Winn MP
    Biochim Biophys Acta; 2007 Aug; 1772(8):859-68. PubMed ID: 17459670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gain-of-function mutations in transient receptor potential C6 (TRPC6) activate extracellular signal-regulated kinases 1/2 (ERK1/2).
    Chiluiza D; Krishna S; Schumacher VA; Schlöndorff J
    J Biol Chem; 2013 Jun; 288(25):18407-20. PubMed ID: 23645677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FK506 ameliorates podocyte injury in type 2 diabetic nephropathy by down-regulating TRPC6 and NFAT expression.
    Ma R; Liu L; Jiang W; Yu Y; Song H
    Int J Clin Exp Pathol; 2015; 8(11):14063-74. PubMed ID: 26823720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose specifically regulates TRPC6 expression in the podocyte in an AngII-dependent manner.
    Sonneveld R; van der Vlag J; Baltissen MP; Verkaart SA; Wetzels JF; Berden JH; Hoenderop JG; Nijenhuis T
    Am J Pathol; 2014 Jun; 184(6):1715-26. PubMed ID: 24731445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Participation of the AngII/TRPC6/NFAT axis in the pathogenesis of podocyte injury in rats with type 2 diabetes.
    Ma R; Xu Y; Zhou H; Zhang D; Yao D; Song L; Liu Y
    Mol Med Rep; 2019 Mar; 19(3):2421-2430. PubMed ID: 30664212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRPC6 mutations associated with focal segmental glomerulosclerosis cause constitutive activation of NFAT-dependent transcription.
    Schlöndorff J; Del Camino D; Carrasquillo R; Lacey V; Pollak MR
    Am J Physiol Cell Physiol; 2009 Mar; 296(3):C558-69. PubMed ID: 19129465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRPC Channels in Proteinuric Kidney Diseases.
    Hall G; Wang L; Spurney RF
    Cells; 2019 Dec; 9(1):. PubMed ID: 31877991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.